The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ixekizumab in Participants With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3323795 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib in Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
- Status
- TERMINATED
- Phase
- PHASE3
A Study of LY3305677 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2775240 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3185643 and rGlucagon in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism
- Status
- UNKNOWN
- Phase
- NA
A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY900014 Formulation in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1